Introduction to DYNAMIKA V.7
DYNAMIKA V.7 has achieved an important milestone by securing the British Standards Institute (BSI) surveillance audit certification, enhancing its credibility and trust in clinical trial imaging.
Innovative Features of DYNAMIKA V.7
With the recent SOC II Type I compliance certification, DYNAMIKA V.7 stands out as a cloud-based platform developed to effectively manage and analyze imaging data for clinical trials. This innovative tool has been designed to support clinical research organizations in their efforts to streamline imaging workflows and improve overall trial efficiency.
Award Recognition
DYNAMIKA was recognized as an Award Category Winner for Innovation at the 2024 Pharmaceutical Technology Excellence Awards. This accolade highlights the platform's potential to drive significant change within the pharmaceutical industry, acknowledging its sophisticated technology that is vital for the development of effective imaging biomarkers.
Commitment to Innovation
Dr. Olga Kubassova, founder and President of Image Analysis Group (IAG), expressed enthusiasm for the platform's advancements, stating, "This milestone is another important step as IAG continues to bring innovation to the medical imaging space." Through DYNAMIKA, IAG aims to partner with organizations focusing on effective imaging biomarkers that enhance the safety and efficacy of drug candidates during clinical trials.
Benefits of Using DYNAMIKA in Clinical Trials
DYNAMIKA offers a variety of advantages tailored to improve medical imaging workflows. Some key benefits include:
Streamlined Imaging Workflows
The platform simplifies and automates imaging processes, resulting in a user-friendly interface that enhances the experience for researchers and sponsors alike.
Enhanced Collaboration
By accelerating the radiological reading process, DYNAMIKA reduces the site burden while simultaneously increasing participation and collaboration among trial sites.
Compliance and Quality Assurance
Adhering to both 21CFR Part 11 regulations—governing electronic records and signatures—and ISO 13485 standards, DYNAMIKA underscores IAG's dedication to maintaining exceptional quality, compliance, and security within clinical research practices. This commitment allows for advancing innovative methods while ensuring patients' safety and data integrity.
About Image Analysis Group (IAG)
Image Analysis Group (IAG) is recognized as a leading imaging Clinical Research Organization (iCRO) that pairs medical expertise with proprietary technologies to streamline drug development. Since 2007, IAG has been dedicated to serving global biotech and pharma clients, reliably supporting phases I to IV imaging trials across various indications.
Contact Information
Brittany Kearns is the primary contact for inquiries related to DYNAMIKA and IAG. With a commitment to excellence, the organization stands ready to assist clients with their imaging needs.
Frequently Asked Questions
What is DYNAMIKA V.7?
DYNAMIKA V.7 is an award-winning cloud platform designed to manage and analyze imaging data effectively in clinical trials.
What recent awards has DYNAMIKA received?
DYNAMIKA was recognized as an Award Category Winner for Innovation at the 2024 Pharmaceutical Technology Excellence Awards.
How does DYNAMIKA enhance collaboration in trials?
It speeds up the radiological reading process, reducing site burden and fostering increased site participation and collaboration.
What compliance standards does DYNAMIKA meet?
DYNAMIKA is developed in accordance with 21CFR Part 11 and ISO 13485, ensuring high standards of quality and data integrity in clinical research.
Who is the primary contact at IAG?
Brittany Kearns serves as the primary contact at Image Analysis Group for inquiries regarding the DYNAMIKA platform and related services.
